# Assessing Factors in Time to Diagnosis for Head-and-Neck Lymphoma

**Authors:** Rishi Kondapaneni, Eric Y Du, Carson K Gates, Vipul K Bhanderi, Patrick T Tassone

PMC · DOI: 10.7759/cureus.93596 · 2025-09-30

## TL;DR

This study examines factors affecting the time to diagnosis for head-and-neck lymphoma, finding that age and symptoms influence how quickly a diagnosis is made.

## Contribution

The study identifies specific clinical factors influencing time to diagnosis in head-and-neck lymphoma and evaluates the role of fine-needle biopsy.

## Key findings

- Older age is associated with longer time to diagnosis for head-and-neck lymphoma.
- Non-lymphadenopathy symptoms are linked to shorter time to diagnosis.
- Fine-needle biopsy by ENT does not significantly delay diagnosis after adjusting for other factors.

## Abstract

Objectives

This study aimed to identify and evaluate factors influencing time to diagnosis (TTD) in head-and-neck (H&N) lymphoma, including fine-needle biopsy (FNA), and identify points of improvement in the management practice of H&N lymphoma.

Methods

This retrospective cohort study was conducted at University of Missouri, a tertiary care health system in Columbia, Missouri. Electronical medical records were reviewed to identify all patients who presented to otolaryngology and were subsequently diagnosed with lymphoma in the H&N region. Demographic and clinical factors influencing TTD, defined as time from initial clinical visit to final pathologic result, were evaluated using Cox proportional hazards multivariable regression modelling and visualized using Kaplan-Meier survival curves.

Results

Our study sample had 137 patients, most of whom presented with the primary symptom of neck mass/lymphadenopathy (81.0%). A personal history of lymphoma (HR 1.81 (1.03, 3.18); p = 0.04) and initial presenting symptoms of other than lymphadenopathy or neck mass (e.g., imaging findings, HR 2.12 (1.26, 3.59); p < 0.01) were factors associated with shorter TTD, whereas older age (HR 0.98 (0.97, 0.99) per year; p < 0.01) portends longer TTD. While FNA completed by ENT had a higher proportion of above median TTD (64.5% vs 40.0%; p < 0.01) on univariate analysis, this finding was not presenting after controlling for covariables (HR 0.93 (0.63, 1.39); p = 0.73).

Conclusion

We identified several factors associated with TTD in H&D lymphoma. FNA for lesions subsequently diagnosed as lymphoma does not clearly lengthen TTD, after controlling for confounders.

## Linked entities

- **Diseases:** lymphoma (MONDO:0003659)

## Full-text entities

- **Diseases:** H&amp;D lymphoma (MESH:D008223), H&amp;N lymphoma (MESH:D006258), lymphadenopathy (MESH:D008206)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12575002/full.md

---
Source: https://tomesphere.com/paper/PMC12575002